Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

GLT

Glatfelter Corporation

May 01 • 04:00PM ET

1.49

Dollar change +0.06
Percentage change 4.20	%

Basic Materials • Paper & Paper Products • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO DFAT IWC DFAC VTWV DFAS

Index	RUT	P/E	-	EPS (ttm)	-1.75	Insider Own	3.37%	Shs Outstand	45.09M	Perf Week	-3.87%
Market Cap	67.27M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	43.62M	Perf Month	-18.13%
Income	-79.05M	PEG	-	EPS next Q	-	Inst Own	80.19%	Short Float	6.61%	Perf Quarter	2.76%
Sales	1.39B	P/S	0.05	EPS this Y	-	Inst Trans	-4.01%	Short Ratio	1.79	Perf Half Y	-11.31%
Book/sh	5.70	P/B	0.26	EPS next Y	-	ROA	-4.86%	Short Interest	2.88M	Perf Year	-66.06%
Cash/sh	1.21	P/C	1.23	EPS next 5Y	0.20%	ROE	-27.17%	52W Range	1.25 - 4.59	Perf YTD	-23.20%
Dividend Est.	-	P/FCF	-	EPS past 5Y	15.44%	ROI	-7.12%	52W High	-67.50%	Beta	1.74
Dividend TTM	-	Quick Ratio	1.10	Sales past 5Y	10.93%	Gross Margin	9.23%	52W Low	19.20%	ATR (14)	0.11
Dividend Ex-Date	Jun 30, 2022	Current Ratio	2.16	EPS Y/Y TTM	59.56%	Oper. Margin	1.54%	RSI (14)	39.43	Volatility	5.72% 6.27%
Employees	2920	Debt/Eq	3.37	Sales Y/Y TTM	-7.10%	Profit Margin	-5.71%	Recom	1.00	Target Price	9.00
Option/Short	Yes / Yes	LT Debt/Eq	3.32	EPS Q/Q	74.90%	Payout	-	Rel Volume	0.20	Prev Close	1.43
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-14.31%	Earnings	May 09 BMO	Avg Volume	1.61M	Price	1.49
SMA20	-8.84%	SMA50	-18.72%	SMA200	-22.09%	Trades		Volume	315,742	Change	4.20%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-21	Upgrade	BMO Capital Markets	Market Perform → Outperform	$17
Apr-20-21	Downgrade	BMO Capital Markets	Outperform → Market Perform	$21 → $19
May-05-17	Upgrade	BMO Capital Markets	Market Perform → Outperform	$23 → $24
Dec-16-15	Initiated	Sidoti	Buy	$25
Aug-07-15	Reiterated	Deutsche Bank	Hold	$25 → $23
Apr-16-14	Reiterated	Deutsche Bank	Buy	$35 → $31
Jan-31-14	Upgrade	Deutsche Bank	Hold → Buy	$31 → $35
Jul-09-13	Downgrade	Deutsche Bank	Buy → Hold	$26 → $26
Mar-27-13	Reiterated	Deutsche Bank	Buy	$21 → $26
Aug-05-09	Upgrade	Deutsche Securities	Hold → Buy	$8 → $14
Feb-13-09	Upgrade	Deutsche Securities	Sell → Hold
Nov-03-08	Downgrade	Deutsche Securities	Buy → Sell
Apr-16-07	Upgrade	Matrix Research	Buy → Strong Buy

Show Previous Ratings

Apr-24-24 04:03PM	Citi Eyes $2 Billion Debt Package for Berry, Glatfelter Deal (Bloomberg)
Apr-17-24 07:15AM	Berry and Glatfelter Announce Regulatory Milestone in Proposed Transaction for Spin-Off and Merger of Berry's Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter (Business Wire) -7.50%
Apr-11-24 06:50AM	Glatfelter Announces Key Leadership Appointments in Connection With Proposed Merger With Berry's Health, Hygiene, and Specialties Global Nonwovens and Films Business (GlobeNewswire)
Apr-04-24 03:06PM	Glatfelter Corporation to Report Earnings on May 9th (GlobeNewswire)
Feb-26-24 03:44PM	Kuehn Law Encourages AGTI, GLT, NGM, and AA Investors to Contact Law Firm (GlobeNewswire)
10:52AM	Loading…
Feb-23-24 10:52AM	Glatfelter Corporation (NYSE:GLT) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:27AM	Q4 2023 Glatfelter Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 04:45PM	Glatfelter (GLT) Q4 2023 Earnings Call Transcript (Motley Fool)
06:52AM	Glatfelter Reports Fourth Quarter and Year End 2023 Results (GlobeNewswire)
Feb-08-24 12:26PM	Kuehn Law Encourages PGTI, AMAM, JNPR, and GLT Investors to Contact Law Firm (GlobeNewswire) -15.91%
01:05AM	Q1 2024 Berry Global Group Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 07:00AM	Berry Global and Glatfelter Announce Plans for Tax-Free Spin-Off and Merger of Berrys Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter, Creating a Global Specialty Materials Leader (Business Wire) +106.25%
Feb-02-24 12:22PM	Glatfelter Corporation to Report Earnings on February 22nd (GlobeNewswire) -7.48%
Jan-30-24 09:00AM	Sontara Announces Partnership with Tzuriel to Strengthen Brand Presence in Latin America (GlobeNewswire)
Nov-05-23 05:57PM	Glatfelter Corporation (NYSE:GLT) Q3 2023 Earnings Call Transcript (Insider Monkey)
05:31AM	Loading…
Nov-03-23 05:31AM	Glatfelter (GLT) Q3 2023 Earnings Call Transcript (Motley Fool) +6.37%
04:50AM	Q3 2023 Glatfelter Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-02-23 06:45AM	Glatfelter Reports Third Quarter 2023 Results (GlobeNewswire)
Oct-27-23 01:09PM	Glatfelter Wins Supplier Award by Rockline Industries (GlobeNewswire)
05:04AM	Carlson Capital L P Boosts Stake in Glatfelter Corp (GuruFocus.com)
Oct-13-23 03:01AM	Carlson Capital L P Adds Glatfelter Corp to Its Portfolio (GuruFocus.com) +6.67%
Oct-10-23 08:45AM	Glatfelter Corporation to Report Earnings on November 2nd (GlobeNewswire)
Oct-05-23 03:03AM	Carlson Capital L P Adds Glatfelter Corp to Its Portfolio (GuruFocus.com)
Sep-26-23 04:10PM	Glatfelter Announces Resignation of Director Lee C. Stewart (GlobeNewswire)
Sep-19-23 09:00AM	Hygienix Innovation Award Finalist: Glatfelters GlatPure Range (GlobeNewswire)
Sep-08-23 07:59AM	Glatfelter & Ekman Initiate Partnership To Sell Abaca Pulp Globally (GlobeNewswire) +11.11%
Sep-07-23 11:02PM	Carlson Capital L P Increases Stake in Glatfelter Corp (GuruFocus.com)
Aug-17-23 11:02PM	Carlson Capital L P Acquires Stake in Glatfelter Corp (GuruFocus.com)
Aug-15-23 06:55AM	Glatfelter Announces Sale of Ober-Schmitten, Germany Facility (GlobeNewswire)
Aug-07-23 04:20PM	Glatfelter Corporation (NYSE:GLT) Q2 2023 Earnings Call Transcript (Insider Monkey) -10.64%
09:00PM	Loading…
Aug-03-23 09:00PM	Glatfelter (GLT) Q2 2023 Earnings Call Transcript (Motley Fool) -20.90%
06:45AM	Glatfelter Reports Second Quarter 2023 Results (GlobeNewswire)
Jul-12-23 03:41PM	Glatfelter Corporation to Report Earnings on August 3rd (GlobeNewswire) +6.17%
Jul-05-23 04:15PM	11 Best Paper Stocks To Buy Now (Insider Monkey) -5.86%
Jun-15-23 09:00AM	Glatfelters GlatPure ADL and Absorbent Core Earns OK Biobased Certification from TUV Austria (GlobeNewswire)
Jun-13-23 08:00AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-01-23 04:47PM	Glatfelter Corporation to present at the Sidoti Summer Small Cap Virtual Conference on June 14th (GlobeNewswire)
May-31-23 06:59AM	Glatfelter Announces Closure of Ober-Schmitten, Germany Facility (GlobeNewswire) -6.82%
May-12-23 06:01AM	Insider Spends US$235k Buying More Shares In Glatfelter \ (Simply Wall St.)
May-05-23 12:30PM	Glatfelter (GLT) Q1 2023 Earnings Call Transcript (Motley Fool) -5.48%
May-04-23 06:45AM	Glatfelter Reports First Quarter 2023 Results (GlobeNewswire) -16.28%
Apr-13-23 10:29AM	Glatfelter to Showcase Newest Product Offerings at INDEX23 (GlobeNewswire)
Apr-07-23 06:40PM	Tillys, American Public Education Stock See Action From Activist Investors (Barrons.com)
11:08AM	Glatfelter Corporation to Report Earnings on May 4th (GlobeNewswire)
Apr-05-23 06:45AM	Glatfelter Appoints New Chief Operating Officer (GlobeNewswire)
Apr-03-23 09:25AM	With 71% ownership of the shares, Glatfelter Corporation (NYSE:GLT) is heavily dominated by institutional owners (Simply Wall St.) +5.33%
08:15AM	Glatfelter Announces Milestone Anniversary for Sontara® (GlobeNewswire)
Mar-30-23 07:18AM	Glatfelter Corporation Announces Successful Completion of Refinancing Plan (GlobeNewswire)
Mar-05-23 12:10PM	7 Penny Stocks With Strong Insider Buying Signals (InvestorPlace)
Feb-28-23 06:43AM	Daily Vickers Top Buyers & Sellers for 02/28/2023 (Argus Research)
Feb-23-23 04:50PM	Glatfelter Corporation to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference (GlobeNewswire)
Feb-21-23 05:00PM	Glatfelter (GLT) Q4 2022 Earnings Call Transcript (Motley Fool) -10.15%
06:45AM	Glatfelter Reports Fourth Quarter and Full Year Results Including Progress Toward Executing Turnaround Strategy (GlobeNewswire)
Feb-18-23 09:21AM	Bullish insiders at Glatfelter Corporation (NYSE:GLT) loaded up on US$1.1m of stock earlier this year (Simply Wall St.)
Feb-08-23 09:59AM	Glatfelter Corporation to Report Earnings on February 21st (GlobeNewswire)
Jan-24-23 10:33AM	Is Glatfelter Corporation (GLT) a Worthy Investment? (Insider Monkey) +5.67%
Jan-22-23 08:52AM	Glatfelter (NYSE:GLT) investors are sitting on a loss of 83% if they invested five years ago (Simply Wall St.)
Dec-26-22 08:05AM	What Is Glatfelter Corporation's (NYSE:GLT) Share Price Doing? (Simply Wall St.)
Nov-16-22 02:59PM	Glatfelter Corporation to Attend the Bank of America 2022 Leveraged Finance Conference (GlobeNewswire) +6.32%
Nov-09-22 05:51AM	Glatfelter Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.) -7.32%
Nov-03-22 05:30PM	Glatfelter (GLT) Q3 2022 Earnings Call Transcript (Motley Fool)
06:45AM	Glatfelter Reports Third Quarter Results Including Turnaround Strategy To Drive Improved Profitability Under New CEO (GlobeNewswire)
Oct-25-22 07:15AM	Glatfelter Corporation (NYSE:GLT) is a favorite amongst institutional investors who own 72% (Simply Wall St.)
Oct-20-22 02:53PM	Glatfelter Corporation to Report Earnings on November 3rd (GlobeNewswire)
Oct-08-22 08:13AM	Calculating The Fair Value Of Glatfelter Corporation (NYSE:GLT) (Simply Wall St.)
Sep-21-22 07:05AM	Glatfelter stock dives after dividend suspended, which had provided near 12% yield (MarketWatch) -5.57%
06:50AM	Glatfelter Suspends Dividend as Part of Capital Allocation Reprioritization (GlobeNewswire)
Sep-06-22 06:12PM	Why Glatfelter Stock Plummeted Today (Motley Fool) -11.74%
Sep-02-22 06:59PM	CoStar Group, Invitation Homes Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 (PR Newswire)
Aug-30-22 07:55AM	Glatfelter says its board fired its CEO but for what reason? (American City Business Journals)
06:21AM	J. Hall Is The Independent Director of Glatfelter Corporation (NYSE:GLT) And They Just Picked Up 23% More Shares (Simply Wall St.)
Aug-26-22 02:01PM	Charlotte manufacturer Glatfelter names Thomas Fahnemann as its new CEO (American City Business Journals) -5.65%
Aug-25-22 06:45AM	Glatfelter Announces Chief Executive Officer Transition (GlobeNewswire) +8.15%
Aug-12-22 06:38AM	Glatfelter (NYSE:GLT) investors are sitting on a loss of 62% if they invested five years ago (Simply Wall St.)
Aug-02-22 10:30PM	Glatfelter (GLT) Q2 2022 Earnings Call Transcript (Motley Fool) -6.78%
06:51AM	Glatfelter Reports Second Quarter 2022 Results (GlobeNewswire)
Jul-21-22 04:48PM	Glatfelter Corporation to Report Earnings on August 2nd (GlobeNewswire) -5.07%
Jul-19-22 06:11AM	At US$6.69, Is Glatfelter Corporation (NYSE:GLT) Worth Looking At Closely? (Simply Wall St.)
Jul-13-22 11:26AM	10 Stocks to Buy According to Carlson Capital (Insider Monkey)
Jun-30-22 11:48AM	Glatfelter, Blue Ocean Closures, and ALPLA take Innovation and Sustainability to the Next Level (GlobeNewswire)
Jun-26-22 08:46AM	Glatfelter (NYSE:GLT) Has Announced A Dividend Of US$0.14 (Simply Wall St.)
Jun-14-22 02:45PM	Sidoti's Summer Small Cap Virtual Conference (ACCESSWIRE)
Jun-10-22 12:25PM	Glatfelter Corporation to present at the Sidoti & Company Summer Small Cap Virtual Conference on June 16th (GlobeNewswire)
Jun-05-22 08:15AM	Glatfelter (NYSE:GLT) Is Due To Pay A Dividend Of US$0.14 (Simply Wall St.)
May-31-22 09:11AM	Make a Change Reimagining Resources to End Period Poverty (GlobeNewswire)
May-26-22 03:45PM	Glatfelter to Participate in the Deutsche Bank Global Materials Conference (GlobeNewswire)
May-21-22 08:01AM	The Senior VP of Glatfelter Corporation (NYSE:GLT), Ramesh Shettigar, Just Bought 116% More Shares (Simply Wall St.)
May-09-22 06:12AM	Glatfelter (NYSE:GLT) Will Pay A Dividend Of US$0.14 (Simply Wall St.) -7.90%
May-05-22 01:32PM	Glatfelter Corporation Declares Dividend of $0.14 per Common Share (GlobeNewswire) -5.86%
May-04-22 02:23PM	Charlotte manufacturer Glatfelter posts big earnings hit from Russia's war on Ukraine (American City Business Journals)
May-03-22 04:30PM	Glatfelter (GLT) Q1 2022 Earnings Call Transcript (Motley Fool) -15.39%
06:50AM	Glatfelter Reports First Quarter 2022 Results (GlobeNewswire)
Apr-29-22 09:42AM	Should Glatfelter Corporation (NYSE:GLT) Focus On Improving This Fundamental Metric? (Simply Wall St.)
Apr-21-22 02:37PM	Glatfelter Corporation to Report Earnings on May 3rd (GlobeNewswire)
Apr-07-22 10:00AM	Glatfelters Sustainable Packaging Solution Wins IDEA® 22 Sustainability Advancement Award (GlobeNewswire)
Apr-04-22 06:55AM	Glatfelter Announces Chief Financial Officer Transition (GlobeNewswire)
Apr-01-22 02:01PM	Glatfelter CEO earns $4.6M compensation package for 2021 (American City Business Journals)
Mar-26-22 01:03PM	Read This Before Considering Glatfelter Corporation (NYSE:GLT) For Its Upcoming US$0.14 Dividend (Simply Wall St.)
Mar-23-22 12:22PM	Glatfelter Corporation to Participate in the NYSE Basic Materials Investor Access Day (GlobeNewswire)
Mar-22-22 09:50AM	Sidoti March Virtual Small Cap Investor Conference (ACCESSWIRE)

Glatfelter Corp. engages in the manufacture of papers and fiber-based engineered materials. It operates through the Composite Fibers and Airlaid Materials segments. The Composite Fibers segment offers food and beverage filtration materials, wallcover base materials, technical specialties, composite laminates decorative laminate solution, and metallized products. The Airlaid Materials segment supplies absorbent and engineered cellulose-based airlaid nonwoven materials for the manufacturing of consumer products for end-user markets. The company was founded by Philip H. Glatfelter in 1864 and is headquartered in Charlotte, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fahnemann Thomas	CEO	Feb 24 '24	Option Exercise	0.00	80,000	0	693,000	Feb 27 04:08 PM
Beck Eileen L	VP, Global Human Resources	Feb 24 '24	Option Exercise	0.00	6,667	0	47,547	Feb 27 03:49 PM
Urey Jill L.	VP, GC & Compliance	Feb 24 '24	Option Exercise	0.00	2,667	0	12,841	Feb 27 03:45 PM
Shettigar Ramesh	Senior VP, CFO & Treasurer	Feb 24 '24	Option Exercise	0.00	13,333	0	46,962	Feb 27 03:53 PM
ELDER DAVID C	Vice Pres, Finance and CAO	Feb 24 '24	Option Exercise	0.00	8,000	0	112,056	Feb 27 03:51 PM
ELDER DAVID C	Vice Pres, Finance and CAO	Feb 18 '24	Option Exercise	2.19	2,455	5,376	99,603	Feb 21 08:17 AM
Beck Eileen L	VP, Global Human Resources	Feb 18 '24	Option Exercise	2.19	2,455	5,376	37,308	Feb 21 08:14 AM
Shettigar Ramesh	Senior VP, CFO & Treasurer	Feb 18 '24	Option Exercise	2.19	1,719	3,765	34,276	Feb 21 08:21 AM
Urey Jill L.	VP, GC & Compliance	Feb 18 '24	Option Exercise	2.19	982	2,151	10,502	Feb 21 08:26 AM
Beck Eileen L	VP, Global Human Resources	Feb 17 '24	Option Exercise	2.19	6,273	13,738	36,976	Feb 20 11:08 AM
ELDER DAVID C	Vice Pres, Finance and CAO	Feb 17 '24	Option Exercise	2.19	6,059	13,269	99,198	Feb 20 01:12 PM
Shettigar Ramesh	Senior VP, CFO & Treasurer	Feb 17 '24	Option Exercise	2.19	3,202	7,012	33,784	Feb 20 01:15 PM
Urey Jill L.	VP, GC & Compliance	Feb 17 '24	Option Exercise	2.19	2,402	5,260	10,318	Feb 20 01:19 PM
CARLSON CAPITAL L P	10% Owner	Oct 26 '23	Buy	1.60	50,000	80,000	7,176,000	Oct 26 07:06 PM
CARLSON CAPITAL L P	10% Owner	Oct 25 '23	Buy	1.55	25,000	38,698	7,126,000	Oct 26 07:06 PM
CARLSON CAPITAL L P	10% Owner	Oct 24 '23	Buy	1.54	75,000	115,320	7,101,000	Oct 26 07:06 PM
CARLSON CAPITAL L P	10% Owner	Oct 10 '23	Buy	1.80	236,000	424,800	7,026,000	Oct 12 05:48 PM
CARLSON CAPITAL L P	10% Owner	Oct 03 '23	Buy	1.90	75,000	142,500	6,790,000	Oct 04 04:05 PM
CARLSON CAPITAL L P	10% Owner	Oct 02 '23	Buy	1.95	250,000	488,425	6,715,000	Oct 04 04:05 PM
STEWART LEE C	Director	Sep 25 '23	Option Exercise	2.01	23,000	46,230	123,719	Sep 27 04:43 PM
CARLSON CAPITAL L P	10% Owner	Sep 06 '23	Buy	2.00	100,000	200,040	6,465,000	Sep 07 05:02 PM
CARLSON CAPITAL L P	10% Owner	Sep 05 '23	Buy	1.92	200,000	384,340	6,365,000	Sep 07 05:02 PM
CARLSON CAPITAL L P	10% Owner	Aug 16 '23	Buy	2.00	65,000	129,954	6,165,000	Aug 17 05:41 PM
CARLSON CAPITAL L P	10% Owner	Aug 15 '23	Buy	2.00	185,000	370,129	6,100,000	Aug 17 05:41 PM
STEWART LEE C	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	100,719	May 16 03:24 PM
Brown Bruce	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	62,865	May 16 04:22 PM
DAHLBERG KATHLEEN	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	105,719	May 16 04:16 PM
Fogarty Kevin Michael	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	73,021	May 16 04:10 PM
Gallagher Marie T.	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	32,528	May 16 04:04 PM
Hackett Darrel H.	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	51,598	May 16 03:57 PM
HALL J ROBERT	Director	May 12 '23	Option Exercise	3.64	14,896	54,221	122,469	May 16 03:51 PM
Shettigar Ramesh	Senior VP, CFO & Treasurer	May 12 '23	Option Exercise	3.64	4,750	17,290	32,162	May 16 03:43 PM
ELDER DAVID C	Vice Pres, Finance and CAO	May 12 '23	Option Exercise	3.64	4,318	15,718	94,341	May 16 03:33 PM
Fogarty Kevin Michael	Director	May 10 '23	Buy	3.63	33,422	121,255	150,000	May 11 11:03 AM
Fogarty Kevin Michael	Director	May 09 '23	Buy	3.49	38,743	135,368	116,578	May 10 03:00 PM
Fogarty Kevin Michael	Director	May 08 '23	Buy	3.58	27,835	99,621	77,835	May 10 03:00 PM

Open in Screener

TFFP

Tff Pharmaceuticals Inc

May 01 • 04:00PM ET

2.67

Dollar change -0.06
Percentage change -2.20	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

TFFP Tff Pharmaceuticals Inc daily Stock Chart

Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-12.68	Insider Own	1.74%	Shs Outstand	2.52M	Perf Week	-11.30%
Market Cap	6.73M	Forward P/E	-	EPS next Y	-5.11	Insider Trans	0.00%	Shs Float	2.48M	Perf Month	-45.84%
Income	-21.24M	PEG	-	EPS next Q	-2.26	Inst Own	15.24%	Short Float	2.81%	Perf Quarter	-50.60%
Sales	0.00M	P/S	-	EPS this Y	54.77%	Inst Trans	11.67%	Short Ratio	2.10	Perf Half Y	-61.93%
Book/sh	4.04	P/B	0.66	EPS next Y	4.66%	ROA	-117.54%	Short Interest	0.07M	Perf Year	-82.12%
Cash/sh	2.17	P/C	1.23	EPS next 5Y	-	ROE	-130.94%	52W Range	2.51 - 21.25	Perf YTD	-61.97%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-13.86%	ROI	-221.31%	52W High	-87.43%	Beta	1.44
Dividend TTM	-	Quick Ratio	3.13	Sales past 5Y	0.00%	Gross Margin	-	52W Low	6.37%	ATR (14)	0.54
Dividend Ex-Date	-	Current Ratio	3.13	EPS Y/Y TTM	56.46%	Oper. Margin	0.00%	RSI (14)	28.23	Volatility	11.79% 12.51%
Employees	19	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	24.50
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	60.48%	Payout	-	Rel Volume	1.41	Prev Close	2.73
Sales Surprise	14.30%	EPS Surprise	5.19%	Sales Q/Q	-	Earnings	Mar 28 AMC	Avg Volume	33.13K	Price	2.67
SMA20	-24.97%	SMA50	-53.19%	SMA200	-63.82%	Trades		Volume	46,791	Change	-2.20%

Date	Action	Analyst	Rating Change	Price Target Change
May-19-22	Resumed	H.C. Wainwright	Buy	$22
Feb-08-21	Initiated	H.C. Wainwright	Buy	$31
Dec-07-20	Initiated	B. Riley Securities	Buy	$36
Aug-17-20	Reiterated	Maxim Group	Buy	$12 → $18
Jul-08-20	Initiated	Maxim Group	Buy	$12

May-01-24 05:07PM	TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering (GlobeNewswire)
Apr-30-24 05:53AM	TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell (MT Newswires)
Apr-29-24 08:00PM	TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.24%
10:00AM	TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM	TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions (GlobeNewswire) -8.57%
10:54PM	Loading…
Mar-28-24 10:54PM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.35%
04:05PM	TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-27-24 04:01PM	TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs (GlobeNewswire)
Mar-25-24 09:01AM	TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Mar-22-24 03:11PM	TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -6.33%
Mar-20-24 12:00PM	TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -10.37%
09:03AM	TFF Pharmaceuticals Announces Update on Clinical Programs (GlobeNewswire)
Mar-14-24 04:47PM	TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference March 17-19, 2024 (GlobeNewswire)
Jan-24-24 08:00AM	TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference (GlobeNewswire) +10.88%
Jan-09-24 08:00AM	TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
10:52AM	Loading…
Dec-20-23 10:52AM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Misses Revenue for Q1 2023 (InvestorPlace) +6.84%
10:52AM	TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q2 2023 (InvestorPlace)
Dec-19-23 06:00AM	TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC (GlobeNewswire) -8.63%
Dec-18-23 04:01PM	TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC (GlobeNewswire)
Dec-15-23 07:00AM	TFF Pharmaceuticals Announces Reverse Stock Split (GlobeNewswire) -14.28%
Dec-13-23 08:00AM	TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors (GlobeNewswire)
Nov-30-23 08:00AM	TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors (GlobeNewswire) +15.48%
08:00AM	TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors (GlobeNewswire)
Nov-27-23 07:00AM	TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference December 7, 2023 (GlobeNewswire)
Nov-16-23 08:37AM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire) +8.14%
Nov-08-23 04:05PM	TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing (GlobeNewswire) -9.85%
Nov-07-23 04:05PM	TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023 (GlobeNewswire) -6.05%
Oct-02-23 05:00PM	TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines (GlobeNewswire)
Sep-28-23 04:29PM	TFF Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
07:00AM	Loading…
Aug-23-23 07:00AM	TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, 2023 (GlobeNewswire) -5.33%
Aug-17-23 04:01PM	TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option (GlobeNewswire)
06:36AM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-16-23 04:25AM	Q2 2023 TFF Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.76%
Aug-15-23 06:05AM	TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire) -8.89%
06:00AM	TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock (GlobeNewswire)
Aug-14-23 04:01PM	TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock (GlobeNewswire) +8.43%
Aug-09-23 08:30AM	TFF Pharmaceuticals to Hold Second Quarter 2023 Financial and Business Results Conference Call on August 15, 2023 (GlobeNewswire)
Aug-08-23 05:50PM	Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Jul-31-23 07:00AM	TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis and Other Voriconazole Responsive Fungal Pulmonary Infections (GlobeNewswire) +11.37%
Jun-26-23 07:00AM	TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine (GlobeNewswire)
May-23-23 04:05PM	TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-11-23 04:05PM	TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-04-23 08:00AM	TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases (GlobeNewswire) +15.64%
May-01-23 07:00AM	TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program (GlobeNewswire)
Apr-08-23 08:58AM	We're A Little Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Rate (Simply Wall St.)
Mar-07-23 04:15PM	TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results (GlobeNewswire)
Mar-06-23 04:05PM	TFF Pharmaceuticals to Participate in the 35th Annual Roth Conference (GlobeNewswire)
Feb-23-23 01:01PM	3 Bargain Stocks Worth Buying at These 52-Week Lows (InvestorPlace) +17.36%
Feb-08-23 04:05PM	TFF Pharmaceuticals Appoints Harlan Weisman, M.D. as Permanent Chief Executive Officer (GlobeNewswire)
Jan-09-23 08:00AM	TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer (GlobeNewswire)
Dec-05-22 06:30AM	TFF Pharmaceuticals Announces Leadership Transition (GlobeNewswire)
Nov-29-22 04:01PM	TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering (GlobeNewswire)
Nov-21-22 01:40PM	15 Most Volatile Stocks to Buy Now (Insider Monkey) +5.98%
Nov-18-22 08:00AM	TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants (GlobeNewswire) -9.30%
Nov-17-22 04:01PM	TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
05:34AM	TFF Pharmaceuticals Third Quarter 2022 Earnings: US$0.29 loss per share (vs US$0.34 loss in 3Q 2021) (Simply Wall St.)
Nov-14-22 04:01PM	TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) -12.43%
Nov-07-22 04:05PM	TFF Pharmaceuticals to Hold Third Quarter 2022 Financial and Business Results Conference Call on November 14, 2022 (GlobeNewswire) -11.67%
Nov-03-22 08:00AM	TFF Pharmaceuticals Announces Collaboration with Aptar Pharma to Explore and Develop Intranasal Delivery of Dry Powder Vaccines and Dry Powder Therapeutics (GlobeNewswire) +14.94%
Nov-02-22 12:47PM	Why TFF Pharmaceuticals Shares Are Sinking Today? (Benzinga) -35.56%
Nov-01-22 04:07PM	TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use Program (GlobeNewswire) +8.00%
04:05PM	TFF Pharmaceuticals Announces Program Updates for Voriconazole Inhaled Powder and Tacrolimus Inhaled Powder Clinical Programs (GlobeNewswire)
Oct-18-22 10:23AM	Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Oct-11-22 08:00AM	TFF Pharmaceuticals Announces Presentation of Data Featuring Applications of Thin Film Freezing Technology at AAPS PharmSci 360 Meeting (GlobeNewswire)
Sep-26-22 08:00AM	TFF Pharmaceuticals to Participate in the Roth Inaugural Healthcare Opportunities Conference (GlobeNewswire) -5.15%
Sep-22-22 08:00AM	TFF Pharmaceuticals Announces Acceptance of Multiple Abstracts Featuring Applications of Thin Film Freezing Technology at the Upcoming AAPS PharmSci 360 Meeting (GlobeNewswire)
Sep-08-22 08:00AM	TFF Pharmaceuticals Announces Presentation of Patient Data with Voriconazole Inhalation Powder (TFF VORI) at the 15th International Congress on Lung Transplantation (GlobeNewswire) +13.60%
Sep-06-22 08:00AM	TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-12-22 11:30AM	TFF Pharmaceuticals, Inc. (TFFP) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-11-22 04:05PM	TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-22 04:05PM	TFF Pharmaceuticals to Hold Second Quarter 2022 Financial and Business Results Conference Call on August 11, 2022 (GlobeNewswire) +6.09%
Jul-14-22 08:00AM	TFF Pharmaceuticals Expands R&D Operations with New Austin Facility (GlobeNewswire)
Jun-24-22 03:44PM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Jun-09-22 08:00AM	TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences Conference (GlobeNewswire)
Jun-01-22 08:00AM	TFF Pharmaceuticals to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-22 09:55AM	Wall Street Analysts Think TFF Pharmaceuticals, Inc. (TFFP) Could Surge 233%: Read This Before Placing a Bet (Zacks) -7.24%
May-20-22 09:32AM	TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-11-22 05:15PM	TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.00%
04:01PM	TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-10-22 03:34PM	Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Invest In Growth? (Simply Wall St.)
May-02-22 08:00AM	TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD) (GlobeNewswire)
Apr-29-22 07:30AM	TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022 (GlobeNewswire)
Apr-28-22 08:04AM	Adicet Bio, Inc. (ACET) Surges 6.8%: Is This an Indication of Further Gains? (Zacks)
Apr-19-22 08:00AM	TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study of Niclosamide Inhalation Powder (GlobeNewswire)
Apr-05-22 09:09PM	2 Stocks Under $10 That This Insider Is Aggressively Buying (TipRanks)
Mar-25-22 12:00AM	TFF Pharmaceuticals, Inc. (TFFP) Q4 2021 Earnings Call Transcript (Motley Fool)
Mar-24-22 05:45PM	TFF Pharmaceuticals, Inc. (TFFP) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:26PM	TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-17-22 11:07AM	TFF Pharma Inks Research Pact With US Army For Dry Powder Medical Countermeasures (Benzinga) +7.49%
08:00AM	TFF Pharmaceuticals Enters into CRADA with the U.S. Army and The Geneva Foundation to Develop Dry Powder Needle-free Medical Countermeasures (GlobeNewswire)
Mar-11-22 07:05AM	TFF Pharmaceuticals to Participate at the 34th Annual Roth Conference (GlobeNewswire)
Mar-09-22 04:05PM	TFF Pharmaceuticals to Hold Fourth Quarter and Full Year 2021 Financial and Business Results Conference Call on March 24, 2022 (GlobeNewswire) +6.53%
Mar-07-22 10:16AM	Catalent's (CTLT) New Tie-Up to Provide Better Patient Access (Zacks) -9.10%
Mar-01-22 08:00AM	TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder Development and Manufacturing Agreement (GlobeNewswire)
Feb-24-22 02:29PM	TFF Pharma's Inhaled Niclosamide Shows Potent Activity Against Omicron Variant (Benzinga) +10.14%
09:27AM	TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2 (GlobeNewswire)
Jan-27-22 08:00AM	TFF Pharmaceuticals Completes Enrollment in Phase 1 Study Evaluating Inhaled Formulation of Niclosamide to Treat COVID-19 (GlobeNewswire) -8.45%
Jan-12-22 09:34AM	TFF Pharmaceuticals, Inc. (NASDAQ:TFFP): Are Analysts Optimistic? (Simply Wall St.)

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CARLSON CAPITAL L P	10% Owner	Aug 16 '23	Sale	0.39	1,000	392	5,064,000	Aug 17 05:29 PM
Weisman Harlan F	President and CEO	Aug 15 '23	Buy	0.25	600,000	150,000	814,615	Aug 15 08:00 AM
Mikhak Zamaneh	Chief Medical Officer	Aug 15 '23	Buy	0.25	120,000	30,000	135,000	Aug 15 08:00 AM
MILLS ROBERT S	Director	Aug 15 '23	Buy	0.25	40,000	10,000	55,980	Aug 15 08:00 AM
COLEMAN KIRK ALLEN	Chief Financial Officer	Aug 15 '23	Buy	0.25	20,000	5,000	35,675	Aug 15 08:00 AM
Roberts Brandi	Director	Aug 15 '23	Buy	0.25	20,000	5,000	20,000	Aug 15 08:00 AM
ROCAMBOLI STEPHEN	Director	Aug 15 '23	Buy	0.25	20,000	5,000	36,000	Aug 15 08:00 AM
CARLSON CAPITAL L P	10% Owner	Aug 15 '23	Sale	0.44	215,000	94,041	5,065,000	Aug 17 05:29 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

GLT

Glatfelter Corporation

TFFP

Tff Pharmaceuticals Inc

Upgrade your FINVIZ experience